Text Size  A-  A  A+


Papers

  1. Alström C, Hallgren B, Nilsson L, Asander H. Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: a specific syndrome (not hitherto described) distinct from the Laurence-Moon-Biedl syndrome. A clinical endocrinological and genetic examination based on a large pedigree. Acta Psychiat Neurol Scand. 1959;34 (suppl 129):1-35.
  2. Marshall JD, Bronson RT, Collin GB, Nordstrom AD, Maffei P, Paisey RB, Carey C, Macdermott S, Russell-Eggitt I, Shea SE, Davis J, Beck S, Shatirishvili G, Mihai CM, Hoeltzenbein M, Pozzan GB, Hopkinson I, Sicolo N, Naggert JK, Nishina PM. New Alstrom syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med. 2005;165:675-683.
  3. Hearn T, Renforth GL, Spalluto C, Hanley NA, Piper K, Brickwood S, White C, Connolly V, Taylor JF, Russell-Eggitt I, Bonneau D, Walker M, Wilson DI. Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alstrom syndrome. Nat Genet. 2002;31:79-83.
  4. Collin GB, Marshall JD, Ikeda A, So WV, Russell-Eggitt I, Maffei P, Beck S, Boerkoel CF, Sicolo N, Matin M. Nishina PM, Naggert JK. Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome. Nat Genet. 2002;31:74-78.
  5. Russell-Eggitt IM, Clayton PT, Coffey R, Kriss A, Taylor DS, Taylor JF Alström Syndrome. Report of 22 cases and literature review. Ophthalmology. 1998 Jul;105(7):1274-80
  6. Bond J, Flintoff K, Higgins J, Scott S, Bennet C, Parsons J, Mannon J, Jafri H, Rashid Y, Barrow M, Trembath R, Woodruff G, Rossa E, Lynch S, Sheilds J, Newbury-Ecob R, Falconer A, Holland P, Cockburn D, Karbani G, Malik S, Ahmed M, Roberts E, Taylor G, Woods CG. The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathy.J Med Genet. 2005 Feb;42(2):e10.
  7. Paisey RB, Carey CM, Bower L, Marshall J, Taylor P, Maffei P, Mansell P. Hypertriglyceridaemia in Alström Syndrome: causes and associations in 37 cases. Clin Endocrinol (Oxf). 2004 Feb;60(2):228-31.
  8. Joy T, Cao H, Black G, Malik R, Charlton-Menys V, Hegele RA, Durrington PN. Alström Syndrome (OMIM 203800): a case report and literature review : Orphanet J Rare Dis. 2007 Dec 21;2(1):49 [Epub ahead of print]
  9. Paisey R B, Williams K,Warren C High vs low carbohydrate meal effects on serum triglyceride and blood glucose levels in five patients with Alström Syndrome. Diabetic Medicine April 2003 20(supplement 2)104-105.
  10. Hodge D A,Williams K, Marshall J, Barratt T, Paisey R Role of insulin treatment for diabetes in Alström Syndrome. Diabetic Medicine, March 2006,23 (supplement 2) 88.
  11. Hearn T, Spalluto C, Phillips VJ, Renforth GL, Copin N, Hanley NA, Wilson DI Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes 1: Diabetes. 2005 May54 (5):
  12. Minton JA, Owen KR, Ricketts CJ, Crabtree N, Shaikh G, Ehtisham S, Porter JR, Carey C, Hodge D, Paisey R, Walker M, Barrett TG. Syndromic obesity and diabetes: changes in body composition with age and mutation analysis of ALMS1 in 12 United Kingdom kindreds with Alström Syndrome. J Clin Endocrinol Metab. 2006 Aug;91(8):3110-6. Epub 2006 May 23.
  13. Smith JC, McDonnell B, Retallick C, McEniery C, Carey C, Davies JS, Barrett T, Cockcroft JR, Paisey R. Is arterial stiffening in Alström Syndrome linked to the development of cardiomyopathy? Eur J Clin Invest. 2007 Feb;37(2):99-105.
  14. Maffei P, Boschetti M, Marshall JD, Paisey RB, Beck S, Resmini E, Collin GB, Naggert JK, Milan G, Vettor R, Minuto F, Sicolo N, Barreca A. Characterization of the IGF system in 15 patients with Alström Syndrome. Clin Endocrinol (Oxf). 2007 Feb;66(2):269-75.
  15. Paisey RB, Hodge D, Williams K. Body fat distribution, serum glucose, lipid and insulin response to meals in Alström Syndrome. J Hum Nutr Diet. 2008 Jun;21(3):268-74.
  16. Paisey RB, Paisey RM, Thomson MP, Bower L, Maffei P, Shield JP, Barnett S, Marshall JD. Protection from clinical peripheral sensory neuropathy in Alström Syndrome in contrast to early-onset type 2 diabetes. Diabetes Care. 2009 Mar;32(3):462-4. Epub 2008 Dec 17.
  17. Khoo EY, Risley J, Zaitoun AM, El-Sheikh M, Paisey RB, Acheson AG, Mansell P. Alström Syndrome and cecal volvulus in 2 siblings. Am J Med Sci. 2009 May;337(5):383-5.
  18. Loudon MA, Bellenger NG, Carey CM, Paisey RB. Cardiac magnetic resonance imaging in Alström Syndrome. Orphanet J Rare Dis. 2009 Jun 10;4:14.
  19. Paisey RB. New insights and therapies for the metabolic consequences of Alström Syndrome. Curr Opin Lipidol. 2009 Aug;20(4):315-20. Review.
  20. Aldahmesh MA, Abu-Safieh L, Khan AO, Al-Hassnan ZN, Shaheen R, Rajab M, Monies D, Meyer BF, Alkuraya FS. Allelic heterogeneity in inbred populations: the Saudi experience with Alström Syndrome as an illustrative example. Am J Med Genet A. 2009 Feb 15;149A(4):662-5.
  21. Lee NC, Marshall JD, Collin GB, Naggert JK, Chien YH, Tsai WY, Hwu WL. Caloric restriction in Alström syndrome prevents hyperinsulinemia. Am J Med Genet A. 2009 Feb 15;149A(4):666-8.

Top of Page